Ocular Therapeutix Inc. buy melinda
Start price
31.10.18
/
50%
€4.40
Target price
08.11.18
€5.59
Performance (%)
2.25%
End price
08.11.18
€4.50
Summary
This prediction ended on 08.11.18 with a price of €4.50. The BUY prediction by melinda finished with a performance of 2.25%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocular Therapeutix Inc. | 2.211% | 2.211% | -21.120% | -71.000% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by melinda for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
SecteurEquipement, fournitures et distribution médicale Agenda 14/11 Publication de résultats
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Nombre d'employés : 119 personnes.
Stopped prediction by melinda for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€6.10
04.03.20
04.03.20
€8.50
04.11.21
04.11.21
-0.82%
05.11.21
05.11.21
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€3.82
04.04.19
04.04.19
€4.06
13.06.19
13.06.19
6.46%
13.06.19
13.06.19
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€7.01
09.02.17
09.02.17
€9.92
21.02.17
21.02.17
18.67%
21.02.17
21.02.17